Anika Therapeutics's total assets for Q3 2024 were $231.41M, a decrease of -11.90% from the previous quarter. ANIK total liabilities were $51.54M for the fiscal quarter, a -1.48% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.